vs
Side-by-side financial comparison of Bandwidth Inc. (BAND) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Bandwidth Inc. is the larger business by last-quarter revenue ($208.8M vs $151.7M, roughly 1.4× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 1.9%, a 5.9% gap on every dollar of revenue. On growth, Bandwidth Inc. posted the faster year-over-year revenue change (20.1% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-1.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 9.7%).
Bandwidth Inc. is a communications platform as a service company. It sells software application programming interfaces for voice, text messaging and emergency services, using its own global IP voice network.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
BAND vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.8M | $151.7M |
| Net Profit | $4.0M | $11.8M |
| Gross Margin | 37.3% | 30.4% |
| Operating Margin | 60.5% | 20.4% |
| Net Margin | 1.9% | 7.8% |
| Revenue YoY | 20.1% | -41.1% |
| Net Profit YoY | 200.0% | -80.8% |
| EPS (diluted) | $-0.08 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $208.8M | — | ||
| Q4 25 | $207.7M | $151.7M | ||
| Q3 25 | $191.9M | $267.8M | ||
| Q2 25 | $180.0M | $244.0M | ||
| Q1 25 | $174.2M | $211.8M | ||
| Q4 24 | $210.0M | $257.6M | ||
| Q3 24 | $193.9M | $78.8M | ||
| Q2 24 | $173.6M | $76.1M |
| Q1 26 | $4.0M | — | ||
| Q4 25 | — | $11.8M | ||
| Q3 25 | $-1.2M | $55.4M | ||
| Q2 25 | $-4.9M | $-17.7M | ||
| Q1 25 | $-3.7M | $21.2M | ||
| Q4 24 | — | $61.6M | ||
| Q3 24 | $413.0K | $-8.8M | ||
| Q2 24 | $4.1M | $-364.0K |
| Q1 26 | 37.3% | — | ||
| Q4 25 | 37.6% | 30.4% | ||
| Q3 25 | 38.5% | 57.8% | ||
| Q2 25 | 39.8% | 51.2% | ||
| Q1 25 | 41.0% | 55.9% | ||
| Q4 24 | 36.4% | 55.0% | ||
| Q3 24 | 37.7% | 27.8% | ||
| Q2 24 | 37.3% | 29.7% |
| Q1 26 | 60.5% | — | ||
| Q4 25 | -1.9% | 20.4% | ||
| Q3 25 | -1.0% | 48.7% | ||
| Q2 25 | -2.1% | 13.8% | ||
| Q1 25 | -2.7% | 38.1% | ||
| Q4 24 | -1.3% | 44.4% | ||
| Q3 24 | -0.5% | 12.3% | ||
| Q2 24 | -3.5% | 7.0% |
| Q1 26 | 1.9% | — | ||
| Q4 25 | — | 7.8% | ||
| Q3 25 | -0.6% | 20.7% | ||
| Q2 25 | -2.7% | -7.3% | ||
| Q1 25 | -2.1% | 10.0% | ||
| Q4 24 | — | 23.9% | ||
| Q3 24 | 0.2% | -11.2% | ||
| Q2 24 | 2.3% | -0.5% |
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $-0.10 | $2.34 | ||
| Q3 25 | $-0.04 | $7.76 | ||
| Q2 25 | $-0.16 | $-2.95 | ||
| Q1 25 | $-0.13 | $3.33 | ||
| Q4 24 | $0.27 | $11.56 | ||
| Q3 24 | $0.01 | $-1.72 | ||
| Q2 24 | $-0.17 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.7M | $329.4M |
| Total Assets | $984.2M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $47.3M | — | ||
| Q4 25 | $111.3M | $185.6M | ||
| Q3 25 | $80.4M | $166.0M | ||
| Q2 25 | $68.1M | $96.7M | ||
| Q1 25 | $41.7M | $84.7M | ||
| Q4 24 | $83.8M | $40.6M | ||
| Q3 24 | $79.9M | $46.9M | ||
| Q2 24 | $76.4M | $40.8M |
| Q1 26 | $405.7M | — | ||
| Q4 25 | $400.0M | $329.4M | ||
| Q3 25 | $392.7M | $317.2M | ||
| Q2 25 | $384.5M | $235.3M | ||
| Q1 25 | $345.4M | $176.9M | ||
| Q4 24 | $312.5M | $132.4M | ||
| Q3 24 | $336.6M | $60.4M | ||
| Q2 24 | $307.4M | $62.7M |
| Q1 26 | $984.2M | — | ||
| Q4 25 | $1.1B | $918.5M | ||
| Q3 25 | $1.0B | $964.5M | ||
| Q2 25 | $1.0B | $841.0M | ||
| Q1 25 | $964.4M | $761.9M | ||
| Q4 24 | $989.2M | $655.3M | ||
| Q3 24 | $1.0B | $438.5M | ||
| Q2 24 | $1.0B | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | $-1.0M | $69.0M |
| FCF MarginFCF / Revenue | -0.5% | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $38.6M | $70.4M | ||
| Q3 25 | $22.2M | $99.5M | ||
| Q2 25 | $31.7M | $27.3M | ||
| Q1 25 | $-3.1M | $51.0M | ||
| Q4 24 | $36.5M | $54.0K | ||
| Q3 24 | $20.5M | $6.8M | ||
| Q2 24 | $24.4M | $13.3M |
| Q1 26 | $-1.0M | — | ||
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | -0.5% | — | ||
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | 49.55× | — | ||
| Q2 24 | 6.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BAND
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
